AI-Powered Single-Cell Multi-Omics Analysis Service

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides an AI-Powered Single-Cell Multi-Omics Analysis Service to address critical challenges in cell therapy development, including limited understanding of CAR-T product heterogeneity, difficulty identifying functional T-cell subpopulations, and insufficient biomarkers for predicting therapeutic efficacy. This service enables comprehensive decoding of CAR-T cellular diversity and functional states through advanced Single-Cell Multi-Omics Analysis technologies and AI-driven multi-omics analytics. By delivering high-resolution characterization of cell populations and molecular signatures, Creative Biolabs supports improved quality assessment, biomarker discovery, and optimization of next-generation cell therapy products.

Introduction

Single-Cell Multi-Omics Analysis technologies enable high-resolution analysis of cellular heterogeneity and molecular states within complex immune populations. These technologies are widely applied in CAR-T research to characterize transcriptional profiles, immune activation pathways, and differentiation states of engineered T cells. Studies demonstrate that single-cell transcriptomic analysis can reveal diverse CAR-T subpopulations, functional states, and mechanisms influencing treatment response and persistence. Such insights support optimization of CAR design, manufacturing processes, and therapeutic efficacy.

Service

At Creative Biolabs, we bridge the gap between massive genomic datasets and actionable therapeutic insights. By applying AI to single-cell data, we move beyond simple cell clustering to provide predictive modeling of how your CAR-T product will behave in vivo. We solve the "heterogeneity problem" by identifying the rare, highly potent sub-populations that drive efficacy while flagging subsets linked to exhaustion or toxicity.

By leveraging single-cell resolution profiling and AI-driven cell population discovery, our platform identifies functional CAR-T subsets, including memory, cytotoxic, and regulatory populations, while using machine-learning algorithms to detect rare phenotypes linked to therapeutic response. Through comprehensive functional state analysis, it evaluates immune activation pathways and differentiation trajectories to clarify CAR-T functionality. Furthermore, the integration of receptor sequencing provides critical insights into clonal expansion and persistence, enabling the identification of biomarkers and gene signatures associated with long-term efficacy, exhaustion, and toxicity risks.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Single-Cell Transcriptomics	Single-Cell Immune Receptor Profiling
High-throughput Single-Cell Multi-Omics Analysis identifies transcriptional signatures across thousands of CAR-T cells, enabling the discovery of activation states, differentiation pathways, and exhaustion markers.	T-cell receptor sequencing at single-cell resolution enables tracking of clonal expansion and persistence of CAR-T cells after infusion.
Single-Cell Epigenomic Profiling	AI-Assisted Data Interpretation
Chromatin accessibility profiling reveals regulatory mechanisms that control CAR-T differentiation, exhaustion, and long-term persistence.	Advanced machine-learning models identify cellular trajectories, predict functional states, and detect biomarkers associated with therapeutic outcomes.

Our Workflow

Required Starting Materials: Clients typically provide cryopreserved or fresh CAR-T infusion products (PBMCs), or longitudinal clinical samples such as patient bone marrow aspirates and peripheral blood collected at defined intervals post-infusion.

Workflow of AI-Powered Single-Cell Multi-Omics Analysis Service. (Creative Biolabs Original)

Final Deliverables: A comprehensive Multi-Omics Interpretive Report, interactive visualization plots of cell clusters, and a predictive Biomarker Discovery matrix.

Core Benefits

Customized AI Model Development: Tailored machine learning algorithms trained on your specific therapeutic targets to minimize black box effects and maximize biological relevance.
Precision Manufacturing Analytics: AI-driven optimization of CD4/CD8 ratios and culture conditions to ensure batch-to-batch consistency.
Clonal Persistence Tracking: Longitudinal TCR-seq monitoring to identify which CAR-T clones expand and persist for years versus those that disappear within weeks.
In Silico Construct Refinement: Rapid directed evolution using protein language models to enhance CAR protein expression and stability.

FAQs

Q: How does AI improve upon standard bioinformatics for CAR-T?

A: Standard methods identify clusters; our AI predicts outcomes. We use supervised learning to correlate single-cell signatures with clinical data, helping you identify which cells actually kill tumors in patients.

Q: Can this service help with solid tumor challenges?

A: We use AI to search single-cell datasets for immunosuppressive shields, helping you design CARs that can penetrate the hostile tumor microenvironment.

Q: What measures are taken to avoid overfitting in the models?

A: We use rigorous quality controls and cross-validation on large, diverse datasets to ensure the patterns we find are biologically real and not just technical noise.

Q: Is my proprietary sequence data safe?

A: We prioritize intellectual property and data protection, operating under strict confidentiality agreements with secure, encrypted data handling protocols.

Partner with Us

Creative Biolabs delivers cutting-edge AI-Powered Single-Cell Multi-Omics Analysis Services, expertly designed to address the intricate challenges of CAR-T heterogeneity, production optimization, and clinical outcome prediction. We transform raw sequencing data into actionable therapeutic insights, driving the development of safer and more potent cell therapies. By integrating advanced artificial intelligence with high-precision sequencing, we streamline research and manufacturing workflows, support reliable clinical forecasting, and help translate complex biological data into tangible therapeutic value. Our dedicated team supports your project from design to delivery, accelerating the advancement of innovative CAR-T treatments for patients worldwide. Contact us today to receive more information and tailor a solution for your project.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.